Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02444247 · ClinicalTrials.gov registry record · NA
Motivation to Exercise
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT02444247: Completed NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT02444247 is a NA study that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 93 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02444247, a NA study, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how to make exercise more attractive to people.
Primary Outcome
RRV of physical activity will be assessed by evaluating the number of responses (mouse button presses) a subject is willing to complete to gain access to physical activity or a sedentary alternative.
Interventions
- OTHER Sedentary Option
- OTHER High Dose Exercise (300 kcal)
- OTHER Low Dose Exercise (150 kcal)
- OTHER No Exercise (0 kcal)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-02 |
| Phase | NA |
What the finished NCT02444247 record still lists
NCT02444247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Sedentary Option is the first listed.
NCT02444247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02444247 about?
NCT02444247 is a clinical study titled "Motivation to Exercise". The purpose of this study is to understand how to make exercise more attractive to people.
What is the current status of trial NCT02444247?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2015-06. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02444247?
The interventions under investigation include: Sedentary Option (OTHER), High Dose Exercise (300 kcal) (OTHER), Low Dose Exercise (150 kcal) (OTHER), No Exercise (0 kcal) (OTHER).
Who is sponsoring clinical trial NCT02444247?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02444247's enrollment target sits among peer trials
93 937th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia